Hemostatic Agent Use

Hemostatic Agent Use is a methodological construct in hemostasis management that refers to the systematic application of pharmacological or biological agents to induce or augment the cessation of bleeding by targeting specific physiological pathways of coagulation.

571

Publications

26.4K

Citations

2.8K

Authors

1K

Institutions

Publications per year

2017–2026

100

Authors

2.8K

  1. İC
    İbrahim C. Haznedaroğlu

    Hacettepe University, Türkiye

    10 publications · 434 citations

    10

    h-index

  2. UH
    Ulla Hedner

    Lund University, Sweden

    8 publications · 433 citations

    8

    h-index

  3. AG
    A. Gringeri

    University of Milan, Italy

    7 publications · 745 citations

    7

    h-index

  4. BS
    Bijan S. Kheirabadi

    United States Army Institute of Surgical Research, United States

    7 publications · 820 citations

    7

    h-index

  5. GY
    Guy Young

    Children's Hospital of Los Angeles, United States

    6 publications · 459 citations

    6

    h-index

1–5 of 2.8K

Venues

  1. PubMed

    Repository · 51 publications · 1.8K citations

    24

    h-index

  2. Haemophilia

    35 publications · 3.5K citations

    21

    h-index

  3. 21

    h-index

  4. Endoscopy

    11 publications · 710 citations

    11

    h-index

  5. Journal of neurosurgery

    JNS · 10 publications · 539 citations

    10

    h-index

1–5